Please use this identifier to cite or link to this item: https://doi.org/10.1186/s12885-018-5215-7
Title: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)
Authors: Tan, Wan-Ling 
Ng, Quan Sing 
Lim, Cindy
Tan, Eng Huat 
Toh, Chee Keong
Ang, Mei-Kim 
Kanesvaran, Ravindran 
Jain, Amit 
Tan, Daniel SW 
Lim, Darren Wan-Teck 
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
Issue Date: 24-Dec-2018
Publisher: BMC
Citation: Tan, Wan-Ling, Ng, Quan Sing, Lim, Cindy, Tan, Eng Huat, Toh, Chee Keong, Ang, Mei-Kim, Kanesvaran, Ravindran, Jain, Amit, Tan, Daniel SW, Lim, Darren Wan-Teck (2018-12-24). Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018). BMC CANCER 18 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-018-5215-7
Abstract: Following publication of the original article [1], the authors notified us of a typographical error in Table 1. The corrected Table 1 is presented below. (Table Presented).
Source Title: BMC CANCER
URI: https://scholarbank.nus.edu.sg/handle/10635/218599
ISSN: 14712407
DOI: 10.1186/s12885-018-5215-7
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Correction to Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases.pdf235.92 kBAdobe PDF

OPEN

PublishedView/Download

SCOPUSTM   
Citations

1
checked on Jan 26, 2023

Page view(s)

72
checked on Jan 26, 2023

Download(s)

1
checked on Jan 26, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.